Form 4: Perrigo Director Alford Reports Routine Equity Transactions

Perrigo Company plc Director Bradley A. Alford reported the acquisition of new Restricted Stock Units and the exercise and tax-related disposal of shares.

Summary

• Bradley A. Alford, a Director of Perrigo Company plc (PRGO), reported transactions involving the company's ordinary shares and Restricted Stock Units (RSUs).
• On June 12, 2026, Mr. Alford acquired 976 ordinary shares at a price of $10.99 per share through the exercise of derivative securities.
• Concurrently, Mr. Alford disposed of 469 ordinary shares at $10.99 per share, likely for tax withholding purposes related to the exercise or vesting of equity awards.
• Following these transactions, Mr. Alford beneficially owns 45,465.148 direct ordinary shares.
• Mr. Alford was granted 2,559 new Restricted Stock Units on June 12, 2026, which are scheduled to vest on June 12, 2027.
• Additionally, 976 Restricted Stock Units, which vested on June 13, 2026, were exercised, resulting in zero beneficially owned derivative securities from that specific grant after the transaction.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. It represents routine insider transactions related to equity compensation and does not indicate a significant positive or negative shift in company fundamentals or prospects.

Positives

• The grant of 2,559 new Restricted Stock Units to Director Bradley A. Alford indicates continued equity incentive and alignment with shareholder interests.
• The exercise of 976 Restricted Stock Units into ordinary shares demonstrates the realization of previously granted equity compensation.

Negatives

• The disposal of 469 ordinary shares at $10.99 per share for tax withholding purposes reduces the director's direct shareholding, though this is a common practice for equity compensation.

Future Outlook

The filing primarily details past and future scheduled equity transactions for a director and does not provide a broader future outlook for the company.

Industry Context

StockSavvy.ai notes that insider transaction filings like Form 4 are routine disclosures required by the SEC. These specific transactions by a director of Perrigo Company plc reflect standard equity compensation practices within the pharmaceutical and consumer health industry, where executives and directors often receive RSUs as part of their remuneration packages.

Comparison to Industry Standards

• The structure of equity compensation, involving Restricted Stock Units that vest over time and subsequent share exercises with tax withholding, is a common practice across publicly traded companies, including peers in the consumer health sector such as Johnson & Johnson (JNJ) or Procter & Gamble (PG).
• The reported share price of $10.99 for the transactions is specific to Perrigo's stock performance around the transaction date and is not directly comparable as an industry standard, but the mechanism of share acquisition and disposal for tax is standard.

Stakeholder Impact

• Shareholders: The transactions represent a routine change in a director's beneficial ownership, with a slight reduction in direct shareholding due to tax withholding, which is a common occurrence and generally has minimal impact on overall shareholder value.
• Employees: No direct impact on employees is indicated by this filing.

Next Steps

• The 2,559 Restricted Stock Units granted on June 12, 2026, are scheduled to vest on June 12, 2027.

Key Dates

Recommendation

This Form 4 filing details routine insider transactions related to equity compensation, specifically the grant of Restricted Stock Units, their exercise, and subsequent share disposals for tax purposes. Such transactions are common and typically do not provide a strong signal for a 'buy' or 'sell' recommendation, as they reflect compensation mechanics rather than a change in the director's fundamental view of the company's prospects. Therefore, a 'hold' recommendation is appropriate, as the filing itself does not present new information that would significantly alter an investment thesis.

Keywords

Perrigo, PRGO, Form 4, Insider Trading, Director, Restricted Stock Units, Equity Compensation, Share Transactions, Beneficial Ownership